The Emerging Therapeutic Landscape of Bullous Pemphigoid: A Systematic Registry-Based Analysis of Clinical Trials (2015-2025)
{{output}}
Background: Bullous pemphigoid (BP) is the most common autoimmune subepidermal blistering disease, with increasing incidence and substantial morbidity in elderly patients. Recent advances in understanding BP pathogenesis have led... ...